Display search results for ** instead (69 products)
27 Jan 2021  |  North America
Efficiency Tools and Workflow Optimization to Drive Future Growth Potential
The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing chan...
29 Oct 2021  |  Global
INNOVATIONS AND GROWTH OPPORTUNITIES IN MEDICAL IMAGING, WEARABLE MEDICAL DEVICES, AND OPHTHALMIC SOLUTIONS
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. This issue includes medical imaging innovations, such as portable MRI, affordable lung X-ray, and ultrasound-based bedside neuronavigation. The issue also profiles few wearable medical ...
27 Jan 2021  |  North America
Advanced Technologies that Enhance Integrated Workflow, Productivity, Patient Safety, and Detection Capabilities Drive the Global Digital Radiography Market
Technology Strategies Shift among Manufacturers with the Emergence of Value-based Imaging
This study presents an analysis of the global digital radiography (DR) market. It provides an in-depth breakdown of current trends, market size, revenue forecast, market penetration, and market attractiveness in 3 segments: turnkey suites, mobile DR, and DR retrofits. Regional Coverage: North America: United States and Canada; Europe: Western Euro...
03 Feb 2021  |  North America
Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market
Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities
2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...
05 Feb 2021  |  North America
Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market
Early-stage R&D and Commercial Applications Fuel the Growth Pipeline
The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...
09 Feb 2021  |  North America
Competitors’ Growth Strategies will Shape the Way the Market Opportunity Crystallizes
There is no one definition for virtual care, but Frost & Sullivan defines it in this research as a technical platform that maintains an interactive connectivity between patients, providers, and payers where various processes and services may be scheduled, accessed, monitored, and entered into the medical record without the need for manual calls or ...
11 Feb 2021  |  Europe
Expansion in Consumer Health and Improved Access to Care Spur New Growth Opportunities
As the rapid spread and impact of COVID-19 continue to cripple healthcare sector providers across Europe, telehealth is emerging as a boon in ensuring efficient access to essential healthcare services. Primary care appointments took a major downturn as people avoided them largely until necessary or were unable to have routine face-to-face visits du...
17 Jun 2021  |  North America
Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential
This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...
23 Jun 2021  |  Global
Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...
23 Jun 2021  |  Global
Advances in RNA Modifications, Formulation, and Stabilization to Drive Growth of RNA Therapeutics
RNA therapeutics is a rapidly expanding area of next-generation biological drugs. RNA is a versatile molecule and naturally regulates gene expression, either by upregulation or downregulation. This function is employed to design novel RNA therapeutics. The fundamentals of RNA therapeutics consists of delivering functional RNA at a target; however, ...